Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study

潜伏性肺结核 肺结核 医学 量子化子 观察研究 一致性 结核菌素 队列 入射(几何) 队列研究 内科学 疾病 结核分枝杆菌 免疫学 病理 物理 光学
作者
Christine Ho,Pei-Jean Feng,Michiko Narita,Jason E. Stout,Michael Chen,Lisa Pascopella,Richard S. Garfein,Randall Reves,Dolly Katz,Jennifer Flood,Lisa Pascopella,Julie Higashi,Kathleen Moser,Monica Moore,Richard S. Garfein,Constance A. Benson,Robert Belknap,Randall Reves,Jason E. Stout,Amina Ahmed,Timothy R. Sterling,April C. Pettit,Henry M. Blumberg,Alawode Oladele,Michael Lauzardo,Marie Nancy Séraphin,Richard Brostrom,Renuka Khurana,Wendy Cronin,Susan E. Dorman,Michiko Narita,David Horné,Thaddeus L. Miller
出处
期刊:Lancet Infectious Diseases [Elsevier BV]
卷期号:22 (1): 85-96 被引量:26
标识
DOI:10.1016/s1473-3099(21)00145-6
摘要

Treatment of latent tuberculosis infection is an important strategy to prevent tuberculosis disease. In the USA, three tests are used to identify latent tuberculosis infection: the tuberculin skin test (TST) and two IFN-γ release assays (T-SPOT.TB and QuantiFERON). To our knowledge, few large studies have compared all three tests among people at high risk of latent tuberculosis infection or progression to tuberculosis disease. We aimed to assess test agreement between IFN-γ release assays and TST to provide guidance on their use in important risk groups.In this observational cohort study, we enrolled participants at high risk of latent tuberculosis infection or progression to tuberculosis disease at ten US sites with 18 affiliated clinics, including close contacts of infectious tuberculosis cases, people born in countries whose populations in the USA have high (≥100 cases per 100 000 people) or moderate (10-99 cases per 100 000 people) tuberculosis incidence, and people with HIV. Participants were interviewed about demographics and medical risk factors, and all three tests were administered to each participant. The primary endpoints for this study were the proportions of positive test results by test type stratified by risk group and test concordance by risk group for participants with valid results for all three test types. The study is registered at ClinicalTrials.gov, NCT01622140.Between July 12, 2012, and May 5, 2017, 26 292 people were approached and 22 131 (84·2%) were enrolled in the study. Data from 21 846 (98·7%) participants were available for analysis, including 3790 (17·3%) born in the USA and 18 023 (82·5%) born outside the USA. Among non-US-born participants overall, the RR comparing the proportions of TST-positive results (7476 [43·2%] of 17 306 participants) to QuantiFERON-positive results (4732 [26·5%] of 17 882 participants) was 1·6 (95% CI 1·6-1·7). The risk ratio (RR) for the comparison with the proportion of T-SPOT.TB-positive results (3693 [21·6%] of 17 118 participants) was 2·0 (95% CI 1·9-2·1). US-born participants had less variation in the proportions of positive results across all tests. The RRs for the proportion of TST-positive results (391 [10·9%] of 3575 participants) compared with the proportion of QuantiFERON-positive results (445 [12·0%] of 3693 participants) and T-SPOT.TB-positive results (295 [8·1%] of 3638 participants) were 0·9 (95% CI 0·8-1·0) and 1·3 (1·2-1·6), respectively. 20 149 (91·0%) of 21 846 participants had results for all three tests, including 16 712 (76%) non-US-born participants. Discordance between TST and IFN-γ release assay results varied by age among non-US-born participants and was greatest among the 848 non-US-born children younger than 5 years. 204 (87·2%) of 234 non-US-born children younger than 5 years with at least one positive test were TST-positive and IFN-γ release assay-negative. The proportion of non-US-born participants who were TST-negative but IFN-γ release assay-positive ranged from one (0·5%) of 199 children younger than 2 years to 86 (14·5%) of 594 participants aged 65 years and older (ptrend<0·0001). Test agreement was higher between the two IFN-γ release assays than between TST and either IFN-γ release assay, regardless of birthplace. κ agreement was particularly low between TST and IFN-γ release assays in non-US-born children younger than 5 years.Our findings support the preferential use of IFN-γ release assays for the diagnosis of latent tuberculosis in high-risk populations, especially in very young and older people born outside the USA.US Centers for Disease Control and Prevention.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
简化为完成签到,获得积分10
刚刚
J_C_Van完成签到,获得积分10
1秒前
橘子树完成签到,获得积分10
2秒前
玛斯特尔完成签到,获得积分10
2秒前
hearz发布了新的文献求助10
2秒前
ZSH完成签到,获得积分10
3秒前
Litoivda完成签到 ,获得积分10
5秒前
暮雨完成签到,获得积分10
6秒前
DOGDAD完成签到,获得积分10
8秒前
英俊的铭应助温柔翰采纳,获得10
8秒前
英姑应助薛建伟采纳,获得10
8秒前
如云完成签到,获得积分20
9秒前
你说的完成签到 ,获得积分10
9秒前
Jasper应助大脸猫4811采纳,获得10
10秒前
hearz完成签到,获得积分10
11秒前
12秒前
P2JY完成签到,获得积分10
12秒前
leiiiiiiii完成签到,获得积分10
12秒前
Bake完成签到 ,获得积分10
14秒前
15秒前
yuan完成签到,获得积分10
15秒前
论文多多完成签到,获得积分10
16秒前
16秒前
Acid完成签到 ,获得积分10
16秒前
1111111111111发布了新的文献求助10
17秒前
linlinyilulvdeng完成签到,获得积分10
17秒前
斯文败类应助历史雨采纳,获得10
18秒前
FashionBoy应助吃个大笼包采纳,获得10
20秒前
海阔天空发布了新的文献求助10
21秒前
薛建伟发布了新的文献求助10
22秒前
高高代珊发布了新的文献求助10
23秒前
害羞的墨镜完成签到,获得积分10
23秒前
lalala发布了新的文献求助10
23秒前
24秒前
guojingjing完成签到,获得积分10
24秒前
打打应助科多兽骑士采纳,获得10
25秒前
angela完成签到,获得积分10
25秒前
25秒前
潇洒的茗茗完成签到 ,获得积分10
27秒前
脂肪小米粥完成签到,获得积分10
28秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066